With personal love and passion we work alone and analyze our favorite shares. May not be many, but they are worth it.
The best online stock broker. Open an account today and start earning up to $1000 of IBKR Stock !
DISCLAIMER:
The financial and technical analycies presented on this website have not been performed by an Investment Services Company, nor have they been compiled by a certified analyst . It is simply a display and presentation of public data of Greek and foreign shares with informative and entertaining character.
Bayer to sell men’s health product Nebido™ to Grünenthal
Supports ongoing transformation of Bayer’s Pharma business to focus on key areas of future medical innovation / Transaction value of up to 500 million Euro / Closing expected by end of 2022
Berlin, July 14, 2022 – Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer’s men’s health product Nebido™ (testosterone undecanoate), for a purchase price totaling up to 500 million Euro.